Dna-Probe, Reagents, Cryptococcal
The Cryptococcal DNA probe reagents are microbiology in vitro diagnostic devices that use nucleic acid hybridization to detect Cryptococcus species in clinical specimens, supporting rapid diagnosis of cryptococcal infections, which are particularly serious in immunocompromised patients. They are classified as FDA Class II under 21 CFR 866.3165 within the Microbiology specialty, requiring 510(k) premarket clearance. The product code is MDE and the device is not implanted. Full GMP compliance is required.
Research product code MDE in seconds
The Research Assistant summarizes clearances, adverse event trends and regulation context for a product code — and cites every record.
Free to try · every answer cites its records
Basic Information
- Product Code
- MDE
- Device Class
- FDA class 2
- Regulation Number
- 866.3165
- Medical Specialty
- Microbiology
- Review Panel
- MI
- Submission Type
- 4
Device Characteristics
510(k) Clearance History
Related 510(k) Clearances
This FDA classification is associated with 1 510(k) clearance via K numbers.
| K Number | Device Name | Decision Date | Decision | Applicant |
|---|---|---|---|---|
| K903556 | ACCUPROBE CRYPTOCOCCUS NEOFORMANS CULTURE TEST | Oct 02, 1990 | Substantially Equivalent | Gen-Probe, Inc. |